Passive Space Radiation Shielding: Mass and Volume Optimization of Tungsten-Doped PolyPhenolic and Polyethylene Resins

The use of commercial, off-the-shelf (COTS) components have become an increasingly attractive option to develop small satellites that satisfy high-quality and reliability, as well as low-cost and development time demands. However, the use of COTS may introduce mission design constraints associated with the mass and volume of appropriate radiation shielding required for various mission lifetime and/or reliability objectives. The purpose of this study is to provide insights towards optimization that minimizes the mass and/or volume of a graded-Z or composite-Z shield. In this study, three model space radiation environments will be attenuated via mass shields using numerical analysis, with a discussion provided on the manufacturability and integration of such shields within the small sat design envelope. The use of graded-Z shielding for multi-particle attenuation is not a new concept. However, as this area of application is yet emerging, few concepts have the development maturity at a Technology Readiness Level of three (TRL-3). Previous design approaches employed an optimization strategy that equally weighed the structural ability of the given system equally against its shielding performance. The current study removes the specific structural constraint, and examines the mass associated with a constant thickness Tungsten-doped PolyPhenolic and Polyethylene resins

Particle Shielding for Human Spaceflight: Electrostatic Potential Effects on the Störmer Magnetic Dipole Exclusion Region

A basic hybrid radiation shield concept, consisting of both a monopole positive electrostatic potential barrier and a current-carrying superconducting solenoid, was predicted to provide a more effective method of shielding a habitable torus region than a solenoid acting alone. A randomized position and velocity vector simulation of equal-energy iron ions using a Lagrangian reference frame was performed on the exact magnetic field integral for the solenoid and a discrete summation electrostatic field for a toroidal monopole array approximating a potential surface. Each particle is injected at a specific energy (100, 150 MeV and 1 GeV). Two cases were evaluated at each particle energy modeling 2x104 particles. The first case studied effects from only the magnetic dipole field (1.1x1013 A m2); the second case evaluated phenomena from a combined magnetic dipole field and electrostatic potential (20 MV). The toroidal electrostatic potential’s influence on the size and shape of the Störmer magnetic dipole exclusion region was examined as the main evaluating criterion against the pure magnetic field results. It was shown that the electrostatic potential influences the size of the Störmer dipole exclusion region, and the ratio of particle energy to electrostatic potential is significant in determining the amount increased. It was found that a low particle energy to electrostatic potential ratio of 5:1 increases Störmer area approximately by a factor of 2

Cost-Effective Icy Bodies Exploration using Small Satellite Missions

It has long been known that Saturn's moon Enceladus is expelling water-rich plumes into space, providing passing spacecraft with a window into what is hidden underneath its frozen crust. Recent discoveries indicate that similar events could also occur on other bodies in the solar system, such as Jupiter's moon Europa and the dwarf planet Ceres in the asteroid belt. These plumes provide a possible giant leap forward in the search for organics and assessing habitability beyond Earth, stepping stones toward the long-term goal of finding extraterrestrial life. The United States Congress recently requested mission designs to Europa, to fit within a cost cap of $1B, much less than previous mission designs' estimates. Here, innovative cost-effective small spacecraft designs for the deep-space exploration of these icy worlds, using new and emerging enabling technologies, and how to explore the outer solar system on a budget below the cost horizon of a flagship mission, are investigated. Science requirements, instruments selection, rendezvous trajectories, and spacecraft designs are some topics detailed. The mission concepts revolve around a comparably small-sized and low-cost Plume Chaser spacecraft, instrumented to characterize the vapor constituents encountered on its trajectory. In the event that a plume is not encountered, an ejecta plume can be artificially created by a companion spacecraft, the Plume Maker, on the target body at a location timed with the passage of the Plume Chaser spacecraft. Especially in the case of Ceres, such a mission could be a great complimentary mission to Dawn, as well as a possible future Europa Clipper mission. The comparably small volume of the spacecraft enables a launch to GTO as a secondary payload, providing multiple launch opportunities per year. Plume Maker's design is nearly identical to the Plume Chaser, and fits within the constraints for a secondary payload launch. The cost-effectiveness of small spacecraft missions enables the exploration of multiple solar system bodies in reasonable timeframes despite budgetary constraints, with only minor adaptations. The work presented here is a summary of concepts targeting icy bodies, such as Europa and Ceres, which have been developed over the last year at NASA Ames Research Center's Mission Design Division. The platforms detailed in this work are also applicable to the cost-effective exploration of many other small icy bodies in the solar system

State of the Art: Small Spacecraft Technology

This report provides an overview of the current state-of-the-art of small spacecraft technology, with particular emphasis placed on the state-of-the-art of CubeSat-related technology. It was first commissioned by NASAs Small Spacecraft Technology Program (SSTP) in mid-2013 in response to the rapid growth in interest in using small spacecraft for many types of missions in Earth orbit and beyond, and was revised in mid-2015 and 2018. This work was funded by the Space Technology Mission Directorate (STMD). For the sake of this assessment, small spacecraft are defined to be spacecraft with a mass less than 180 kg. This report provides a summary of the state-of-the-art for each of the following small spacecraft technology domains: Complete Spacecraft, Power, Propulsion, Guidance Navigation and Control, Structures, Materials and Mechanisms, Thermal Control, Command and Data Handling, Communications, Integration, Launch and Deployment, Ground Data Systems and Operations, and Passive Deorbit Devices

BLOOM: A 176B-Parameter Open-Access Multilingual Language Model

Large language models (LLMs) have been shown to be able to perform new tasks based on a few demonstrations or natural language instructions. While these capabilities have led to widespread adoption, most LLMs are developed by resource-rich organizations and are frequently kept from the public. As a step towards democratizing this powerful technology, we present BLOOM, a 176B-parameter open-access language model designed and built thanks to a collaboration of hundreds of researchers. BLOOM is a decoder-only Transformer language model that was trained on the ROOTS corpus, a dataset comprising hundreds of sources in 46 natural and 13 programming languages (59 in total). We find that BLOOM achieves competitive performance on a wide variety of benchmarks, with stronger results after undergoing multitask prompted finetuning. To facilitate future research and applications using LLMs, we publicly release our models and code under the Responsible AI License

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

The effect of implementing an automated oxygen control on oxygen saturation in preterm infants

OBJECTIVE: To evaluate the effect of implementing automated oxygen control as routine care in maintaining oxygen saturation (SpO2) within target range in preterm infants. METHODS: Infants 95% decreased (41.9 (30.6-49.4)% vs 19.3 (11.5-24.5)%; p<0.001). The time SpO2<90% increased (8.6 (7.2-11.7)% vs 15.1 (14.0-21.1)%; p<0.0001), while SpO2<80% was similar (1.1 (0.4-1.7)% vs 0.9 (0.5-2.1)%; ns). CONCLUSIONS: During oxygen therapy, preterm infants spent more time within the SpO2 target range after implementation of automated oxygen control, with a significant reduction in hyperoxaemia, but not hypoxaemia

BioSentinel: Monitoring DNA Damage Repair Beyond Low Earth Orbit on a 6U Nanosatellite

We are designing and developing a “6U” nanosatellite as a secondary payload to fly aboard NASA’s Space Launch System (SLS) Exploration Mission (EM) 1, scheduled for launch in late 2017. For the first time in over forty years, direct experimental data from biological studies beyond low Earth orbit (LEO) will be obtained during BioSentinel’s 12 to 18-month mission. BioSentinel will measure the damage and repair of DNA in a biological organism and compare that to information from onboard physical radiation sensors. This data will be available for validation of existing models and for extrapolation to humans. The BioSentinel experiment will use the organism Saccharomyces cerevisiae (yeast) to report DNA double-strand-break (DSB) events that result from space radiation. DSB repair exhibits striking conservation of repair proteins from yeast to humans. The flight strain will include engineered genetic defects that prevent growth and division until a radiation-induced DSB activates the yeast’s DNA repair mechanisms. The triggered culture growth and metabolic activity directly indicate a DSB and its repair. The yeast will be carried in the dry state in independent microwells with support electronics. The measurement subsystem will sequentially activate and monitor wells, optically tracking cell growth and metabolism. BioSentinel will also include TimePix radiation sensors implemented by JSC’s RadWorks group. Dose and Linear Energy Transfer (LET) data will be compared directly to the rate of DSB-and-repair events measured by the S. cerevisiae biosentinels. BioSentinel will mature nanosatellite technologies to include: deep space communications and navigation, autonomous attitude control and momentum management, and micropropulsion systems to provide an adaptable nanosatellite platform for deep space uses